Pharming Group N.V. (PHAR) Capital expenditures 2019–2025
Pharming Group N.V. (PHAR) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$749,000FY2025 · since FY2019: $2.6M → $749,000
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $749,000 | -5.2% |
| FY2024 | $790,000 | -45.0% |
| FY2023 | $1.4M | +4.4% |
| FY2022 | $1.4M | -87.2% |
| FY2021 | $10.7M | +130.6% |
| FY2020 | $4.7M | +75.9% |
| FY2019 | $2.6M | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice